The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Resiliency in the operating room is imperative in today’s health care climate. A well-functioning OR has the potential to increase the number of…
Webcast
Brent Petty, executive industry consultant, Healthcare Lexmark International, discusses what forces are currently affecting health care and the pla
On-Demand Educational Webinars
This session is a comprehensive approach to understanding Lean Management System concepts, processes, tools, and their application to improving…
Podcasts
Cybersecurity vulnerabilities and intrusions pose risks for every hospital and its reputation.
Webcast
Allen Archer, System Director of Supply Chain at Houston Healthcare, leads a thought-leader panel discussion about the role of GPOs within the chan
On-Demand Educational Webinars
Learn how to drive organizational and cultural improvements by utilizing cost, quality, and outcome data in the decision making process. This webinar…